| pubmed-article:9357454 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9357454 | lifeskim:mentions | umls-concept:C0021775 | lld:lifeskim |
| pubmed-article:9357454 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
| pubmed-article:9357454 | lifeskim:mentions | umls-concept:C2936666 | lld:lifeskim |
| pubmed-article:9357454 | lifeskim:mentions | umls-concept:C0282440 | lld:lifeskim |
| pubmed-article:9357454 | lifeskim:mentions | umls-concept:C1096777 | lld:lifeskim |
| pubmed-article:9357454 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9357454 | pubmed:dateCreated | 1997-11-25 | lld:pubmed |
| pubmed-article:9357454 | pubmed:abstractText | Percutaneous transluminal angioplasty (PTA) is an increasingly popular invasive treatment for peripheral arterial disease, but there have been very few controlled trials to justify its use. This randomized controlled clinical trial was performed to determine in patients with mild and moderate intermittent claudication differences in outcome between PTA and conventional medical treatment after 2 years. | lld:pubmed |
| pubmed-article:9357454 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9357454 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9357454 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9357454 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9357454 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9357454 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:9357454 | pubmed:issn | 0741-5214 | lld:pubmed |
| pubmed-article:9357454 | pubmed:author | pubmed-author:HousleyEE | lld:pubmed |
| pubmed-article:9357454 | pubmed:author | pubmed-author:RuckleyC VCV | lld:pubmed |
| pubmed-article:9357454 | pubmed:author | pubmed-author:FowlerG FGF | lld:pubmed |
| pubmed-article:9357454 | pubmed:author | pubmed-author:LeeA JAJ | lld:pubmed |
| pubmed-article:9357454 | pubmed:author | pubmed-author:WhymanM RMR | lld:pubmed |
| pubmed-article:9357454 | pubmed:author | pubmed-author:GillespieI... | lld:pubmed |
| pubmed-article:9357454 | pubmed:author | pubmed-author:KerracherE... | lld:pubmed |
| pubmed-article:9357454 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9357454 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:9357454 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9357454 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9357454 | pubmed:pagination | 551-7 | lld:pubmed |
| pubmed-article:9357454 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:meshHeading | pubmed-meshheading:9357454-... | lld:pubmed |
| pubmed-article:9357454 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9357454 | pubmed:articleTitle | Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. | lld:pubmed |
| pubmed-article:9357454 | pubmed:affiliation | Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh, Scotland, United Kingdom. | lld:pubmed |
| pubmed-article:9357454 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9357454 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9357454 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9357454 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9357454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9357454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9357454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9357454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9357454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9357454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9357454 | lld:pubmed |
